The Tunisia Pharmaceutical Market size was valued at USD 1.5 billion in 2023 and is projected to reach USD 3.51 billion by 2032, exhibiting a CAGR of 12.9 % during the forecasts period. The market for medicines in Tunisia is a vibrant and involves the manufacturing, trading, as well as the sale of prescription, as well as off counter, drugs. This market spans across all health care related issues such as chronic ailments control, acute illness and even proactive health measures. The applications cut across hospitals, clinics, pharmacies, and many more research organizations. Trends include rising investment in local products to give lesser dependence on imports, rise in the generic drugs production, and development in biotechnology. There is also an increase in business models of digital health solutions and e-pharmacy services due to technological integration and governmental encouragement. With the advancement in healthcare needs of the populations, the Tunisia pharmaceutical market also changes with an aim of adopting the key factors such as access, cost and quality.

In Tunisia Pharmaceutical Market, Sanofi launched Toujeo and SoloStar, a new pre-filled pen for long-acting insulin (glargine) used to treat diabetes.

Pharmaceuticals in Dosage Market Size Value in Tunisia, 2021 Discover more data with ReportLinker!

Tunisia IPI: Manufacturing: Chemical: Pharmaceutical Industry data was reported at 140.200 2000=100 in Dec 2014. This records an increase from the previous number of 124.100 2000=100 for Nov 2014. Tunisia IPI: Manufacturing: Chemical: Pharmaceutical Industry data is updated monthly, averaging 103.300 2000=100 from Jan 2000 (Median) to Dec 2014, with 180 observations. The data reached an all-time high of 155.400 2000=100 in Sep 2014 and a record low of 62.300 2000=100 in Jul 2010. Tunisia IPI: Manufacturing: Chemical: Pharmaceutical Industry data remains active status in CEIC and is reported by National Statistics Institute. The data is categorized under Global Database’s Tunisia – Table TN.B002: Industrial Production Index: 2000=100.

The global pharmaceutical market is expected to grow at a CAGR of 5% during 2011-2017, exceeding sales worth US$ 1.1 Trillion by 2017. This market, however, is expected to undergo a number of transitions which would impact the course of its growth. These transitions include a shift of growth from the developed to the emerging markets, an increasing focus on biopharmaceuticals compared to small molecule drugs and an increasing preference for generics compared to their branded versions. As a result of these transformations; the need for a user friendly, robust and comprehensive pharmaceutical market intelligence has become imperative for investors, researchers, consultants, marketing strategists, and all those who are planning to foray into the pharmaceutical market in some form or the other.

IMARC Group, one of the world’s leading research and advisory firms, introduces a new and revolutionary way to understand and evaluate the global pharmaceutical market with its Microsoft Excel based report entitled “Global Pharmaceutical Market Report & Forecast: 2012-2017”. This report provides an analytical and statistical insight into the global pharmaceutical market. The study, which has been undertaken using desk based as well as primary market research has analyzed the following aspects of the global pharmaceutical market.

What We Have Achieved in This Report?

Regions Covered: Global, North America, Europe, Asia Pacific, Latin America & Caribbean and Middle East & Africa

Countries Covered in Each Region

North America: United States and Canada

Europe: Germany, France, Italy, Spain, United Kingdom, Russia, Turkey, Netherlands, Poland, Greece, Belgium, Switzerland, Austria, Sweden, Portugal, Hungary, Romania, Denmark, Czech Republic, Finland, Ireland, Norway, Slovakia, Bulgaria, Croatia, Slovenia, Lithuania, Latvia, Luxembourg and Estonia

Asia Pacific: Japan, China, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Pakistan, Vietnam, Bangladesh, Hong Kong, New Zealand, Malaysia and Singapore

Latin America & Caribbean:Brazil, Mexico, Venezuela, Argentina, Puerto Rico, Colombia, Chile, Ecuador, Peru, Dominican Republic and Uruguay

Middle East & Africa: South Africa, Egypt, Saudi Arab, Algeria, Morocco, United Arab Emirates Lebanon, Tunisia, Jordan and Kuwait

Focus of the Analysis:

• Historical sales performance (2007-2011) for each country
• Historical sales performance (2007-2011) for each region
• Sales forecast (2012-2017) for each country
• Sales forecast (2012-2017) for each region
• Sales performance of key manufacturers for each country (2007-2011)
• Sales performance of key therapeutic areas for each country (2007-2011)
• Country wise sales breakup for each region (2007-2011)
• Country wise sales breakup forecast for each region (2012-2017)

Key Questions Answered;

• What was the historical performance of the global pharmaceutical market?
• Which are the key regions and countries in the global pharmaceutical market?
• Which are the largest pharmaceutical markets in the world?
• Which are the fastest growing pharmaceutical markets in the world?
• Which markets are expected to witness the slowest growth in the coming years?
• Which countries represent the key markets for each region?
• What has been the performance of various therapeutic classes in each country?
• Who are the top pharmaceutical manufacturers in each country?
• What are the market shares of the top pharmaceutical manufacturers in each country?

Why You should Buy This Report?

• To gain a comprehensive understanding on the historical, current and future pharmaceutical market trends across 70 countries in 6 regions.
• To identify potential regions, countries, therapeutic areas, partners and competitors for market entry and expansion plans.
• As a tool for developing investment strategies by identifying the biggest winners and losers across various regions and countries.
• To ensure a successful M&A and partnership strategy by identifying therapeutic areas and companies with the most promising outlook.

The Tunisian pharmaceutical rubber articles market shrank to $21M in 2024, waning by -6.2% against the previous year. In general, consumption, however, recorded a relatively flat trend pattern. Pharmaceutical rubber articles consumption peaked at $23M in 2023, and then declined in the following year.

Colombia Exports of pharmaceutical products to Tunisia was US$4.39 Thousand during 2011, according to the United Nations COMTRADE database on international trade. Colombia Exports of pharmaceutical products to Tunisia - data, historical chart and statistics - was last updated on September of 2025.

Statistics illustrates most promising overseas markets of pharmaceutical goods; appliances identifiable for ostomy use in Tunisia from 2007 to 2024.

Tunisia Imports from Vietnam of Pharmaceutical products was US$133.08 Thousand during 2023, according to the United Nations COMTRADE database on international trade. Tunisia Imports from Vietnam of Pharmaceutical products - data, historical chart and statistics - was last updated on July of 2025.

As of December 2020, during the coronavirus (COVID-19) pandemic, ** percent of the businesses operating in the chemical and pharmaceutical industry in Tunisia improved their information technology (IT) infrastructures. The same was done by ** percent of information and telecommunication companies in the country.

Tunisia Exports of hygienic or pharmaceutical articles of vulcanized rubber to France was US$4.35 Thousand during 2016, according to the United Nations COMTRADE database on international trade. Tunisia Exports of hygienic or pharmaceutical articles of vulcanized rubber to France - data, historical chart and statistics - was last updated on September of 2025.

In 2024, the Tunisian veterinary medicine vaccines market decreased by -11.2% to $18M for the first time since 2021, thus ending a two-year rising trend. Overall, consumption, however, enjoyed a resilient expansion. Over the period under review, the market attained the maximum level at $20M in 2023, and then shrank in the following year.

Tunisia Imports from Poland of Hygienic or Pharmaceutical Articles of Vulcanized Rubber was US$45 during 2021, according to the United Nations COMTRADE database on international trade. Tunisia Imports from Poland of Hygienic or Pharmaceutical Articles of Vulcanized Rubber - data, historical chart and statistics - was last updated on August of 2025.

In June 2020, the majority of businesses operating in the private sector in Tunisia registered a decline in sales due to the economic impact of the coronavirus (COVID-19), compared to the previous year. The mechanical, electronic, and construction industries were heavily impacted, each with almost ** percent of their enterprises recording a decrease in sales. Signs of recovery were observed the following month (July 2020), with the loss shares decreasing for almost every sector. The chemical and pharmaceutical industry was the least affected in June, but it was the only one worsening in July 2020.

For the fifth year in a row, the Tunisian medical gel preparations market recorded growth in sales value, which increased by 2.3% to $9.6M in 2024. The market value increased at an average annual rate of +1.4% over the period from 2012 to 2024; the trend pattern indicated some noticeable fluctuations being recorded in certain years. Medical gel preparations consumption peaked at $11M in 2018; however, from 2019 to 2024, consumption remained at a lower figure.

Credit report of Taha Pharma Residence Tunis Carthag contains unique and detailed export import market intelligence with it's phone, email, Linkedin and details of each import and export shipment like product, quantity, price, buyer, supplier names, country and date of shipment.

IPI：制造业：化学品：制药行业在12-01-2014达140.2002000年=100，相较于11-01-2014的124.1002000年=100有所增长。IPI：制造业：化学品：制药行业数据按月更新，01-01-2000至12-01-2014期间平均值为103.3002000年=100，共180份观测结果。该数据的历史最高值出现于09-01-2014，达155.4002000年=100，而历史最低值则出现于07-01-2010，为62.3002000年=100。CEIC提供的IPI：制造业：化学品：制药行业数据处于定期更新的状态，数据来源于Institut National de la Statistique，数据归类于Global Database的突尼斯 – 表 TN.B002：工业生产指数：2000年=100。